These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35332698)

  • 1. Urinary clearance of 11-nor-9-carboxy-Δ
    Sempio C; Huestis MA; Kaplan B; Klawitter J; Christians U; Henthorn TK
    Drug Test Anal; 2022 Aug; 14(8):1368-1376. PubMed ID: 35332698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2020 Jan; 44(1):1-14. PubMed ID: 31095692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.
    Schlienz NJ; Cone EJ; Herrmann ES; Lembeck NA; Mitchell JM; Bigelow GE; Flegel R; LoDico CP; Hayes ED; Vandrey R
    J Anal Toxicol; 2018 May; 42(4):232-247. PubMed ID: 29300962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.
    Schwilke EW; Gullberg RG; Darwin WD; Chiang CN; Cadet JL; Gorelick DA; Pope HG; Huestis MA
    Addiction; 2011 Mar; 106(3):499-506. PubMed ID: 21134021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
    Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
    Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
    Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users.
    Huestis MA; Blount BC; Milan DF; Newmeyer MN; Schroeder J; Smith ML
    Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.
    Gustafson RA; Kim I; Stout PR; Klette KL; George MP; Moolchan ET; Levine B; Huestis MA
    J Anal Toxicol; 2004 Apr; 28(3):160-7. PubMed ID: 15107145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of postmortem concentrations of Δ
    Hoffman MA; Trochta A; Gary RD; Fitzgerald RL; McIntyre IM
    Forensic Sci Int; 2020 Oct; 315():110414. PubMed ID: 32738674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine.
    Beardsley GD; Christensen JM
    Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):67-78. PubMed ID: 21469505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Nov; 137(2-3):196-202. PubMed ID: 14609657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
    Schuster RM; Potter K; Vandrey R; Hareli M; Gilman J; Schoenfeld D; Evins AE
    J Psychopharmacol; 2020 Feb; 34(2):197-210. PubMed ID: 31535597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-nor-9-carboxy-Δ
    Hanisch S; Paulke A; Toennes SW
    J Pharm Biomed Anal; 2017 Nov; 146():261-265. PubMed ID: 28892757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of urinary metabolites of cannabidiol, Δ
    Sim YE; Kim JW; Ko BJ; Kim JY; Cheong JC; Pyo J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123568. PubMed ID: 36527808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.